Kazia Therapeutics Ltd (KZIA)
CIK 1075880 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kazia Therapeutics Ltd.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Nov 2, 2026 | NT 20-F | 0001193125-26-443609 |
| Oct 2, 2026 | SCHEDULE 13G/A | 0002044285-26-000010 |
| Sep 22, 2026 | 424B3 | 0001213900-26-101975 |
| Sep 22, 2026 | 424B3 | 0001213900-26-101971 |
| Sep 22, 2026 | 424B3 | 0001213900-26-101974 |
| Sep 22, 2026 | 6-K | 0001213900-26-101967 |
| Sep 22, 2026 | 424B3 | 0001213900-26-101972 |
| Sep 18, 2026 | 424B3 | 0001213900-26-101401 |
| Sep 18, 2026 | 424B3 | 0001213900-26-101403 |
| Sep 18, 2026 | 424B3 | 0001213900-26-101404 |
| Sep 18, 2026 | 424B3 | 0001213900-26-101402 |
| Sep 18, 2026 | 6-K | 0001213900-26-101400 |
| Sep 1, 2026 | 424B3 | 0001213900-26-096266 |
| Sep 1, 2026 | 6-K | 0001213900-26-096263 |
| Sep 1, 2026 | 424B3 | 0001213900-26-096267 |
| Sep 1, 2026 | 424B3 | 0001213900-26-096268 |
| Sep 1, 2026 | 424B3 | 0001213900-26-096265 |
| Aug 31, 2026 | 424B3 | 0001213900-26-095351 |
| Aug 31, 2026 | 6-K | 0001213900-26-095310 |
| Aug 31, 2026 | 424B3 | 0001213900-26-095353 |
| Aug 31, 2026 | 424B5 | 0001213900-26-095303 |
| Aug 31, 2026 | 424B3 | 0001213900-26-095355 |
| Aug 31, 2026 | 424B3 | 0001213900-26-095349 |
| Aug 31, 2026 | 6-K | 0001213900-26-095348 |
| Aug 28, 2026 | 424B5 | 0001213900-26-094600 |